R.G. Shanks

3.0k total citations
84 papers, 2.4k citations indexed

About

R.G. Shanks is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, R.G. Shanks has authored 84 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 12 papers in Pharmacology. Recurrent topics in R.G. Shanks's work include Cardiac electrophysiology and arrhythmias (20 papers), Analytical Methods in Pharmaceuticals (12 papers) and Heart Rate Variability and Autonomic Control (10 papers). R.G. Shanks is often cited by papers focused on Cardiac electrophysiology and arrhythmias (20 papers), Analytical Methods in Pharmaceuticals (12 papers) and Heart Rate Variability and Autonomic Control (10 papers). R.G. Shanks collaborates with scholars based in United Kingdom, Bangladesh and United States. R.G. Shanks's co-authors include D. M. Dunlop, D. G. McDevitt, J.W. Black, D. A. D. Montgomery, D. R. Hadden, Dermot Lowe, S. George Carruthers, John Allen, J. A. Weaver and K.J. Hutchison and has published in prestigious journals such as The Lancet, Circulation and Circulation Research.

In The Last Decade

R.G. Shanks

83 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.G. Shanks United Kingdom	25	993	534	330	296	269	84	2.4k
Bengt Åblad Sweden	21	746 0.8×	498 0.9×	330 1.0×	228 0.8×	130 0.5×	52	1.7k
B. N. C. Prichard United Kingdom	27	1.3k 1.4×	430 0.8×	305 0.9×	564 1.9×	470 1.7×	117	2.9k
J. L. McNay United States	27	1.1k 1.1×	533 1.0×	348 1.1×	605 2.0×	213 0.8×	93	3.1k
JL Reid United Kingdom	33	1.5k 1.6×	781 1.5×	536 1.6×	407 1.4×	513 1.9×	166	3.6k
Thomas E. Gaffney United States	27	626 0.6×	355 0.7×	169 0.5×	195 0.7×	204 0.8×	55	1.9k
Charles A. Chidsey United States	39	2.7k 2.7×	765 1.4×	485 1.5×	583 2.0×	285 1.1×	78	4.5k
Gordon S. Stokes Australia	26	805 0.8×	473 0.9×	283 0.9×	237 0.8×	422 1.6×	130	2.0k
R. G. Shanks United Kingdom	19	481 0.5×	414 0.8×	156 0.5×	197 0.7×	89 0.3×	47	1.5k
William A. Pettinger United States	26	1.0k 1.1×	871 1.6×	378 1.1×	392 1.3×	438 1.6×	74	2.8k
Peter E. Pool United States	26	1.7k 1.7×	483 0.9×	221 0.7×	305 1.0×	240 0.9×	57	2.5k

Countries citing papers authored by R.G. Shanks

Since Specialization

Citations

This map shows the geographic impact of R.G. Shanks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.G. Shanks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.G. Shanks more than expected).

Fields of papers citing papers by R.G. Shanks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.G. Shanks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.G. Shanks. The network helps show where R.G. Shanks may publish in the future.

Co-authorship network of co-authors of R.G. Shanks

This figure shows the co-authorship network connecting the top 25 collaborators of R.G. Shanks. A scholar is included among the top collaborators of R.G. Shanks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.G. Shanks. R.G. Shanks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pringle, T H, J. G. Riddell, & R.G. Shanks. (1988). Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man. European Journal of Clinical Pharmacology. 35(5). 507–514. 23 indexed citations

Harron, D. W. G., et al.. (1988). Effect of acute administration of propranolol and atenolol on baroreflex function in normal man. European Journal of Clinical Pharmacology. 35(6). 607–612. 7 indexed citations

Barber, J M, et al.. (1985). Very early intervention with metoprolol in suspected acute myocardial infarction. European Heart Journal. 6(3). 190–198. 40 indexed citations

Wilson, Robert F., et al.. (1985). Suppression of Ventricular Arrhythmias After Coronary Artery Ligation by Pinacidil, a Vasodilator Drug. Journal of Cardiovascular Pharmacology. 7(5). 875–883. 45 indexed citations

Shanks, R.G.. (1984). Hemodynamic effects of mexiletine. American Heart Journal. 107(5). 1065–1071. 15 indexed citations

Campbell, N P, et al.. (1984). Prophylactic lidocaine in suspected acute myocardial infarction. International Journal of Cardiology. 5(1). 96–98. 30 indexed citations

Kelly, John G., R.G. Shanks, & D. G. McDevitt. (1983). Influence of ranitidine on plasma metoprolol concentrations. BMJ. 287(6400). 1218.3–1219. 7 indexed citations

Nicholls, DP, D. W. G. Harron, & R.G. Shanks. (1981). ACUTE AND CHRONIC CARDIOVASCULAR EFFECTS OF INDORAMIN AND PRAZOSIN IN NORMAL MAN. British Journal of Clinical Pharmacology. 12(s1). 18 indexed citations

Griffiths, Kathryn, et al.. (1980). Debendox and congenital malformations in Northern Ireland.. BMJ. 281(6252). 1379–1381. 22 indexed citations

10.

Carson, Ian, Seán Lyons, & R.G. Shanks. (1979). ANTI-ARRHYTHMIC DRUGS. British Journal of Anaesthesia. 51(7). 659–670. 20 indexed citations

11.

Arnold, J. Malcolm O., et al.. (1977). The effects of heart rate, myocardial ischemia and vagal stimulation on the threshold for ventricular fibrillation.. Circulation. 55(2). 311–317. 48 indexed citations

12.

McDevitt, D. G., R.G. Shanks, & B. N. C. Prichard. (1976). The Clinical Pharmacology of Beta Adrenergic Blocking Drugs. Journal of the Royal College of Physicians of London. 11(1). 21–34. 14 indexed citations

13.

Prichard, B. N. C., D. G. McDevitt, & R.G. Shanks. (1976). Uses of Beta-Adrenoceptor Blocking Drugs. Journal of the Royal College of Physicians of London. 11(1). 35–57. 9 indexed citations

14.

Carruthers, S. George, J.G. Kelly, D. G. McDevitt, R.G. Shanks, & Michael J. Walsh. (1973). Duration of action of beta-blocking drugs.. BMJ. 2(5859). 177.2–177. 22 indexed citations

15.

Kelly, J.G. & R.G. Shanks. (1971). Adrenoceptors mediating metabolic responses in the greyhound.. PubMed Central. 41(2). 389P–390P. 2 indexed citations

16.

Montgomery, D. A. D., Dermot Lowe, R.G. Shanks, & J. A. Weaver. (1969). Drug treatment of thyrotoxicosis.. BMJ. 3(5661). 55.1–55. 3 indexed citations

17.

Dunlop, D. M. & R.G. Shanks. (1969). Inhibition of the carotid sinus reflex by the chronic administration of propranolol. British Journal of Pharmacology. 36(1). 132–143. 28 indexed citations

18.

Brick, I., K.J. Hutchison, D. G. McDevitt, I. C. Roddie, & R.G. Shanks. (1968). Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. British Journal of Pharmacology. 34(1). 127–140. 106 indexed citations

19.

Glover, W. E. & R.G. Shanks. (1963). The mechanism of the response of the chronically sympathectomized forearm to intravenous adrenaline. The Journal of Physiology. 167(2). 263–267.

20.

Waugh, William H. & R.G. Shanks. (1960). Cause of Genuine Autoregulation of the Renal Circulation. Circulation Research. 8(4). 871–888. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact